Inlexzo System
Product Images NDC 57894-225

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 34 technical images submitted to the FDA as part of the official labeling for Inlexzo (NDC 57894-225). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Janssen Biotech, Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Inlexzo 01)

FDA Label Image

Image (Inlexzo 02)

FDA Label Image

Image (Inlexzo 03)

Image (Inlexzo 03)
This text likely refers to items that are safe to use in a magnetic resonance (MR) environment, meaning they do not contain any ferrous materials that could cause harm or interfere with the MRI scanner. These items can be safely used during MRI scans without any risk.*
FDA Label Image

Image (Inlexzo 04)

FDA Label Image

Image (Inlexzo 05)

FDA Label Image

Image (Inlexzo 06)

Image (Inlexzo 06)
This text mentions an "Exit Port" and a urinary catheter with a green Coudé tip and depth markings. Additionally, it references a translucent stylet hub. This suggests it is describing a medical device used for urinary catheterization.*
FDA Label Image

Image (Inlexzo 07)

FDA Label Image

Image (Inlexzo 08)

FDA Label Image

Image (Inlexzo 09)

FDA Label Image

Image (Inlexzo 10)

FDA Label Image

Image (Inlexzo 11)

FDA Label Image

Image (Inlexzo 12)

FDA Label Image

Image (Inlexzo 13)

FDA Label Image

Image (Inlexzo 14)

FDA Label Image

Image (Inlexzo 15)

FDA Label Image

Image (Inlexzo 16)

FDA Label Image

Image (Inlexzo 17)

FDA Label Image

Image (Inlexzo 18)

FDA Label Image

Image (Inlexzo 19)

FDA Label Image

Image (Inlexzo 20)

FDA Label Image

Image (Inlexzo 21)

FDA Label Image

Image (Inlexzo 22)

FDA Label Image

Image (Inlexzo 23)

FDA Label Image

Image (Inlexzo 24)

FDA Label Image

Image (Inlexzo 25)

FDA Label Image

Image (Inlexzo 26)

FDA Label Image

Image (Inlexzo 27)

FDA Label Image

Image (Inlexzo 28)

FDA Label Image

Image (Inlexzo 29)

FDA Label Image

Image (Inlexzo 30)

FDA Label Image

Image (Inlexzo 31)

FDA Label Image

Image (Inlexzo 32)

FDA Label Image

Image (Inlexzo 33)

FDA Label Image

Principal Display Panel (225 mg Intravesical System Box)

Principal Display Panel (225 mg Intravesical System Box)
This is a description of the Inlexzo™ intravesical system containing 225mg of gemcitabine intended for intravesical use only. The contents include a sterile single-dose gemcitabine intravesical system, a sterile urinary catheter (Fr) and a sterile green stylet, MRI Safety information card, and instructions for use. It is manufactured by Johnson & Johnson. The recommended dosage can be found in the prescribing information. It should be stored in the original carton at a temperature range of 20°C to 25°C (68°F to 77°F) with excursions permitted between 15°C to 30°C (59°F to 86°F). For further assistance or to provide feedback on Inlexzo™, one can call 1-800-526-7736.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.